Animal Vaccines Market, by Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines), by Application (Companion Animal, Livestock Animal, Poultry, and Aquac

Animal Vaccines Market, by Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines), by Application (Companion Animal, Livestock Animal, Poultry, and Aquaculture), by Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Animal vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. These vaccines are parenteral products that are used in prophylactic treatment of various diseases such as blastomycosis, psittacosis cat scratch disease, and others.
Market Dynamics
Vaccines are preventive medicines for the treatment of various diseases. Some of the vaccines are expensive to afford. So various companies operating in the global animal vaccines market offer reimbursement to reduce the expenses of pet vaccinations which is expected to augment the market growth over the forecast period. For instance, For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection Moreover, Elanco reimburses standard and reasonable diagnostics (a biopsy and histopathological exam) to reach a definitive diagnosis. With a confirmed diagnosis, Elanco reimburses standard and reasonable treatment costs up to US$ 1,500. For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection.
Moreover, various pet health insurance companies provide coverage for vaccines, examinations, teeth cleaning, spaying, and other pet health related activities. Some of the pet health insurance companies include ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, and PetPlan, Allstate Insurance Company, among others.
Key features of the study:
This report provides an in-depth analysis of the global animal vaccines market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global animal vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies.
Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global animal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal vaccines market
Detailed Segmentation:
Global Animal Vaccines Market, By Product Type :
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Global Animal Vaccines Market, By Application:
Companion Animal
Livestock Animal
Poultry
Aquaculture
Global Animal Vaccines Market, By Distribution Channel:
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Others
Global Animal Vaccines Market, By Region:
North America
By Product Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
By Application
Companion Animal
Livestock Animal
Poultry
Aquaculture
By Distribution Channel
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Others
By Country
U.S.
Canada
Latin America
By Product Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
By Application
Companion Animal
Livestock Animal
Poultry
Aquaculture
By Distribution Channel
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
By Application
Companion Animal
Livestock Animal
Poultry
Aquaculture
By Distribution Channel
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
By Application
Companion Animal
Livestock Animal
Poultry
Aquaculture
By Distribution Channel
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
By Application
Companion Animal
Livestock Animal
Poultry
Aquaculture
By Distribution Channel
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Product Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
By Application
Companion Animal
Livestock Animal
Poultry
Aquaculture
By Distribution Channel
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Others
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Merck & Co., Inc.*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Boehringer Ingelheim International GmbH.
Zoetis Inc.
Elanco Animal Health Incorporated
Ceva
HIPRA
Romvac Company Sa
Biovac
Vaxxinova International BV
Biogénesis Bagó
“*” marked represents similar segmentation in other categories in the respective section.